Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis

被引：0
|
作者：
Bradley A. Warady
Eric Ng
Laura Bloss
May Mo
Franz Schaefer
Justine Bacchetta
机构：
[1] Children’s Mercy Kansas City,Division of Pediatric Nephrology
[2] Amgen Inc.,undefined
[3] Heidelberg University Hospital,undefined
[4] Department of Pediatric Nephrology,undefined
[5] Rheumatology and Dermatology,undefined
[6] Femme Mère Enfant Hospital,undefined
来源：
Pediatric Nephrology | 2020年 / 35卷
关键词：
Cinacalcet; CKD-MBD; Dialysis; Pediatric; sHPT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1679 / 1697
页数：18
相关论文
共 50 条
  • [41] Cinacalcet and the prevention of secondary hyperparathyroidism in rats with aldosteronism
    Selektor, Yelena
    Ahokas, Robert A.
    Bhattacharya, Syamal K.
    Sun, Yao
    Gerling, Ivan C.
    Weber, Karl T.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2008, 335 (02): : 105 - 110
  • [42] Cinacalcet is efficacious in pediatric dialysis patients
    Douglas M. Silverstein
    Kanwal K. Kher
    Asha Moudgil
    Mona Khurana
    Jennifer Wilcox
    Kathleen Moylan
    Pediatric Nephrology, 2008, 23 : 1817 - 1822
  • [43] Cinacalcet is efficacious in pediatric dialysis patients
    Silverstein, Douglas M.
    Kher, Kanwal K.
    Moudgil, Asha
    Khurana, Mona
    Wilcox, Jennifer
    Moylan, Kathleen
    PEDIATRIC NEPHROLOGY, 2008, 23 (10) : 1817 - 1822
  • [44] Cinacalcet not cost-effective in secondary hyperparathyroidism
    不详
    Nature Clinical Practice Nephrology, 2007, 3 (6): : 303 - 303
  • [45] Cinacalcet and the prevention of secondary hyperparathyroidism in rats with aldosteronism
    Selektor, Y.
    Ahokas, R. A.
    Bhattacharya, S. K.
    Sun, Y.
    Gerling, I. C.
    Weber, K. T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 425 - 425
  • [46] Cinacalcet - The first calcimimetic approved for secondary hyperparathyroidism
    Dang, DK
    FORMULARY, 2004, 39 (10) : 482 - +
  • [47] Efficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism
    Urena-Torres, Pablo
    Bridges, Ian
    Christiano, Cynthia
    Cournoyer, Serge H.
    Cooper, Kerry
    Farouk, Mourad
    Kopyt, Nelson P.
    Rodriguez, Mariano
    Zehnder, Daniel
    Covic, Adrian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (05) : 1241 - 1254
  • [48] Cinacalcet HCl controls secondary hyperparathyroidism (HPT) regardless of gender, race, age, and geography in patients with chronic kidney disease (CKD) receiving dialysis.
    Coyne, DW
    Stegman, MH
    Azad, H
    Joy, MS
    Mischel, SF
    Pokroy, N
    Ouseph, R
    Gokal, R
    Brink, HS
    Jadoul, M
    Olson, KA
    Albizem, MB
    Klassen, PS
    Chertow, GM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 464A - 464A
  • [49] Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism
    Behets, Geert J.
    Spasovski, Goce
    Sterling, Lulu R.
    Goodman, William G.
    Spiegel, David M.
    De Broe, Marc E.
    D'Haese, Patrick C.
    KIDNEY INTERNATIONAL, 2015, 87 (04) : 846 - 856
  • [50] Hypophosphatemia and hungry bone syndrome in a dialysis patient with secondary hyperparathyroidism treated with cinacalcet - Proposal for an improved monitoring
    Nowack, Rainer
    Wachtler, Paul
    CLINICAL LABORATORY, 2006, 52 (11-12) : 583 - 587
12345